Related by context. Frequent words. (Click for all words.) 63 Patent Application 57 Shelf Registration Statement 57 Paragraph IV 57 FDA Clearance 56 Pivotal Phase III 54 Drug Candidate 54 Exclusive License 54 Patent 54 Complete Response 54 FDA Accepts 53 Biologics License Application 53 RNAi Therapeutics 53 REUTERS Fred Prouser 53 Preclinical Data 53 Clinical Trial Results 53 Generic Version 53 ANDAs 53 Extended Release 53 Monoclonal Antibody 52 END FOOTNOTE 52 Small Molecule 52 Patient Enrollment 52 Phase III Clinical Trial 52 Biologics License Application BLA 52 Investigational 51 Patents 51 INDs 51 Files Patent 51 Patent Litigation 51 Pivotal Trial 51 Compl 50 Marketing Authorization 50 REUTERS Mario Anzuoni 50 sBLA 50 Marketing Authorization Application 50 Orphan Drug Designation 50 Interim Filings 50 Permanent Injunction 50 Polymeric 50 Orphan Drug Status 50 Receives Patent 50 Apricus Bio 50 Pivotal Phase 50 Clevudine 50 Antisense 50 Defendant Motion 50 REUTERS Ray Stubblebine 50 PATENT 50 REUTERS Gary Hershorn 50 Image #K GIF [001] 49 Completes Enrollment 49 FDA Clears 49 Ampligen R 49 REUTERS Rick Wilking 49 TREANDA 49 ADVEXIN 49 Pulmonary Arterial Hypertension 49 Low Dose 49 Anti TNF 49 Defendants Motion 49 IMPAX Laboratories Inc. 49 Doc. No. 49 Ceragenix 49 Panzem R 49 Dkt 49 FDA Orphan Drug 49 Ceftobiprole 49 Patent Infringement 49 Imagenetix 49 Bone Graft 49 Rotarix R 49 Patent Nos. #,#,# 49 '# '# 48 Plaintiff Motion 48 Belinostat 48 Annual Filings 48 submitted Marketing Authorization 48 humanized anti 48 '# patents 48 Investigational Device Exemption 48 Nucleic Acid 48 Phase III Trial 48 Presents Positive 48 Quantum Dots 48 Intellipharmaceutics 48 Synthon 48 patent 48 Securities andExchange Commission 48 Qualifying Therapeutic Discovery 48 Zelrix 48 Paragraph IV certification 48 Pirfenidone 48 Pharmexa 48 Patent Portfolio 48 Natalizumab 48 PMA submission 48 supplemental Biologics License Application 48 Fidaxomicin 48 Fast Track Designation 48 therapeutic monoclonal antibodies 47 '# Patent